A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumor (CAREFNDR (CRN00808-12))

Principal Investigator

Dr Bahram Jafar-Mohammadi

Contact us

Email: diabetes.research1@ouh.nhs.uk

IRAS number

1011549